IDEAYA Biosciences Grants Stock Options to New Employees under Nasdaq Rule
IDEAYA Biosciences granted non-qualified stock options to five newly hired employees under its 2023 Inducement Incentive Award Plan, in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $29.10 per share and a 10-year term, vesting over four years. The move is aimed at attracting new talent to the company.
Tickers: $IDYA
Topics: employee compensation equity grants Nasdaq Listing Rule 5635(c)(4) stock options